| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/20/2006 | WO2006075776A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 07/20/2006 | WO2006075642A1 Hypoxia response enhancing agent |
| 07/20/2006 | WO2006074925A1 Purine derivatives acting as a2a receptor agonists |
| 07/20/2006 | WO2006054162A8 Azabicyclic muscarinic receptor antagonists |
| 07/20/2006 | WO2006015060A3 Isoindoline compounds and methods of their use |
| 07/20/2006 | WO2005072704A3 Method of treating acute rhinosinusitis |
| 07/20/2006 | US20060161004 Quinoline derivatives for therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper-reactivity, cough, inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160816 Pirazino(AZA) indole derivatives |
| 07/20/2006 | US20060160813 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis |
| 07/20/2006 | US20060160808 New carboxylic acid derivatives, their preparation and their use |
| 07/20/2006 | US20060160771 Aminophosphonic acid derivatives, addition salts thereof and sip receptor modulators |
| 07/20/2006 | US20060160768 Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 07/20/2006 | US20060160726 Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors |
| 07/20/2006 | US20060160132 Diagnositics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 07/20/2006 | US20060159761 for therapy of allergic and/or inflammatory conditions of the skin and airway passages; desloratadine-pseudoephedrine once-a-day product which produces a release rate profile for pseudoephedrine over an extended period in excess of twelve hours while maintaining delivery of desloratadine |
| 07/20/2006 | US20060159749 Mesalamine inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices |
| 07/20/2006 | US20060159697 Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof |
| 07/20/2006 | US20060159629 Perforated; standard particle size; nonaggregating; flowability, dispersibility; lower dosage inhalants |
| 07/20/2006 | DE102005001297A1 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum Aerosol formulation for inhalation containing an anticholinergic |
| 07/20/2006 | CA2594675A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 07/20/2006 | CA2593398A1 Purine derivatives acting as a2a receptor agonists |
| 07/19/2006 | EP1680105A2 Use of glucosidase inhibitors for therapy of mucovisidosis |
| 07/19/2006 | EP1483284B1 Selective dipeptide inhibitors of kallikrein |
| 07/19/2006 | EP1395575B1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 07/19/2006 | EP1294721B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/19/2006 | EP1283725B1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof |
| 07/19/2006 | EP1268453B1 Estrogen agonist/antagonist metabolites |
| 07/19/2006 | EP1214129B1 Process for producing fine medicinal substances |
| 07/19/2006 | EP1056452B1 Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 07/19/2006 | EP0941083B1 Pharmaceutical compositions containing 3-iodo-1,2-propanediol having mucolytic activity |
| 07/19/2006 | CN1805957A Azetidine compounds |
| 07/19/2006 | CN1805935A Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor |
| 07/19/2006 | CN1805927A 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 07/19/2006 | CN1805753A Treatment of severe acute respiratory syndrome (SARS) |
| 07/19/2006 | CN1804039A Virulence genes, proteins, and their use |
| 07/19/2006 | CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists |
| 07/19/2006 | CN1803168A Traditional Chinese medicine for treating severe acute respiration syndrome (SARS) |
| 07/19/2006 | CN1803162A Rhinological disease-treating pharmaceutical compositions and its preparing method |
| 07/19/2006 | CN1803155A Medicine for curing rhinitis |
| 07/19/2006 | CN1803152A Pest-clearing toxicide |
| 07/19/2006 | CN1803132A Ramatroban pharmaceutical composition |
| 07/19/2006 | CN1264843C Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 07/19/2006 | CN1264840C 8-methoxy-(1,2,4) triazolo (1,5-A) pyridine derivatives and their use as adenosine receptor ligands |
| 07/19/2006 | CN1264828C Nitric ester and nitrate salts of specific drugs |
| 07/19/2006 | CN1264819C Process for stereo selective synthesis of prostacyclin derivatives |
| 07/19/2006 | CN1264554C Chinese drug composition for treating viral infection of upper respiratory tract and preparing process thereof |
| 07/19/2006 | CN1264544C Nasal suppository for treating thinitis and its preparation method |
| 07/19/2006 | CN1264535C Capsule for dispersing phlegm and descending qi and its preparation method |
| 07/18/2006 | US7078565 Benzamide derivatives as antagonists of orexin receptors |
| 07/18/2006 | US7078522 2-heterocycle-7-oxo-pyrido-[2,3-d]-pyrimidines or 2-oxo-7-heterocycle-1,6-naphthyridines; phosphodiesterase V inhibitors; erectile dysfunction; side effect reduction |
| 07/18/2006 | US7078492 Human antipneumococcal antibodies from non-human animals |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078417 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078412 3(R)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2] octane in salt form, particularly bromide or trifluoroacetate, for treatment of respiratory disorders, alone or in combination with other bronchodilatory compounds |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | CA2313629C Method for transferring one or more active ingredients between different phase carriers |
| 07/13/2006 | WO2006073197A1 1-thio-d-glucitol derivatives |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072564A1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 07/13/2006 | WO2006057902A3 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 07/13/2006 | WO2006057901A3 2-METHYLENE-19-NOR-1α-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES |
| 07/13/2006 | WO2006008003A3 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154976 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 07/13/2006 | US20060154969 Adenosine receptor selective modulators |
| 07/13/2006 | US20060154944 N-(3,5-dimethylphenyl)-1-(3-fluorophenyl)-1,9-dihydrospiro[ beta-carboline-4,1'-cyclopropane]-2(3H)-carboxamide;affinity for mitochondrial benzodiazepine receptors preventive/therapeutic to stress-related diseases; irritable bowel syndrome; anxiolytic agents; nervous/respiratory system disorders;asthma |
| 07/13/2006 | US20060154920 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij] quinoline derivatives as antipsychotic and antiobesity agents |
| 07/13/2006 | US20060154896 Phosphorylated dextrans |
| 07/13/2006 | US20060154868 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/13/2006 | US20060153880 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis |
| 07/13/2006 | US20060153837 Treating autoimmune diseases with humanized anti-CD401 antibodies |
| 07/13/2006 | US20060153803 administering a combination of genetic engineered interferon and ribavirin to in vitro cells capable of being infected with RNA viruses; prevention of severe acute respiratory syndrome (SARS) |
| 07/13/2006 | CA2592614A1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 07/12/2006 | EP1679296A1 Ether derivative |
| 07/12/2006 | EP1679067A1 Concurrent drugs |
| 07/12/2006 | EP1679064A2 Pharmaceutical compositions containing rapamycin derivatives |
| 07/12/2006 | EP1678175A2 Cftr channel modulators |
| 07/12/2006 | EP1678156A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 07/12/2006 | EP1677796A2 Muscarinic acetylcholine receptor antagonists field of the invention |
| 07/12/2006 | EP1677795A1 Muscarinic acetycholine receptor antagonists |
| 07/12/2006 | EP1677782A2 Inhibitors of cathepsin s |
| 07/12/2006 | EP1677628A2 Composition for the activation of the immune system |
| 07/12/2006 | EP1427732B1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a|pyrazol-1-ones which control inflammatory cytokines |
| 07/12/2006 | EP1335923B1 Condensed pyridoindole derivatives |
| 07/12/2006 | EP0971743B1 Stabilized medicaments containing cysteinyl derivatives |
| 07/12/2006 | EP0900235B1 Fragments of cr1 and their use |
| 07/12/2006 | EP0788359B1 Combination of dextromethorphan with quinidine or quinine sulfate for treating a variety of intractable disorders |
| 07/12/2006 | CN1802377A Tricyclic compound |
| 07/12/2006 | CN1802357A Aminopyrimidine derivatives and their medical use |
| 07/12/2006 | CN1802162A Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |